News | EP Lab | February 02, 2021

Patient Data From Several Cardiac Devices Streamlined Into One Platform With New Cloud-based Software

Optimize EP launches CaRM cardiac device data management platform to automates workflow processes and enhances data algorithms

The Optimize EP CaRM software integrates data from several EP devices a patients may use and aggregate it into one location.

The Optimize EP CaRM software integrates data from several EP devices a patients may use and aggregate it into one location. 


February 2, 2021 – Optimize EP, a digital health company focused on transforming cardiac care by improving the current state of cardiac data management, recently emerged from stealth mode to announce the launch of CaRM, the company’s unique cloud-based software that streamlines patient data from multiple electrophysiology (EP) cardiac devices onto one accessible and easy-to-use platform. 

Founded by Maninder Bedi, M.D., who also serves as the company’s chief medical officer, Optimize EP incorporates both enterprise performance management (EPM) and electronic medical record (EMR) systems effortlessly into the CaRM software. It features data algorithms designed specifically to help physicians, clinical teams and administrators overcome the challenges associated with codifying and simplifying the immense amount of remote monitoring data transmitted each day so care teams can deliver improved and differentiated patient care. 

“Remote monitoring has the potential to dramatically improve patient care, but the reality of managing cardiac device data is daunting; it can be chaotic and time-consuming,” Bedi said, who is a practicing electrophysiologist with Regional Cardiac Arrhythmia in Steubenville, Ohio. “CaRM can streamline data from both implantable and external devices and features a number of automated processes that simplify day-to-day workflow, making it possible for clinical teams to devote more time to treating more patients.” 

CaRM integrates a variety of hospital and clinic billing software programs, ensuring the accuracy of reimbursement codes and the essential capture of associated revenue. The platform can be customized to create unique alerts and notifications, increasing the functionality and simplicity of the interface. CaRM also syncs directly with the FDA’s product recall page, automatically and immediately alerting physicians to any FDA recall announcements impacting their patients’ devices, giving them the opportunity to adjust treatment strategies and alter care quickly. 

“On the clinical side of things, CaRM can make patient care easier, but for hospitals and clinics, it can also strengthen their operational margins,” said Ravi Kartan, president and CEO of Optimize EP. “CaRM is an invaluable tool for those EPs and cardiologists who own their practices and rely on intuitive technologies like ours to keep things up and running. It’s a practical digital tool for sustainability and profitability.” 

CaRM is commercially available in the United States.

Founded in 2018, Optimize EP is a digital health company focused on transforming cardiology care by improving cardiac data management to create sustainable, profitable practices that deliver optimal patient care. CaRM, the company’s proprietary software developed by a practicing electrophysiologist, is a cloud-based platform that improves efficiency and streamlines the clinical and administrative operations necessary for efficient cardiac device remote monitoring, reimbursement and billing.

For more information: https://www.optimizeep.com


Related Content

Feature | Cardiac Diagnostics | By Robert L. Quigley, MD, DPhil

Atherosclerotic cardiovascular disease (ASCVD), caused by plaque buildup in arterial walls, is one of the leading causes ...

Home January 23, 2024
Home
News | Cardiac Diagnostics

September 5, 2023 — GE HealthCare announced the launch of a handheld, wireless ultrasound imaging system designed for ...

Home September 05, 2023
Home
Feature | Cardiac Diagnostics | By Kelly Patrick

The global ambulatory diagnostic cardiology market was valued at $2.6 billion in 2022 and is forecast to rise to $3.3 ...

Home May 15, 2023
Home
News | Cardiac Diagnostics

February 8, 2023 — Results of research that identified new causes of Atherosclerotic Coronary Artery Disease, or ASCAD ...

Home February 08, 2023
Home
News | Cardiac Diagnostics

September 15, 2022 - Happitech has announced the launch of its FastStart Research app. The Amsterdam-based digital ...

Home September 15, 2022
Home
Feature | Cardiac Diagnostics | by Kelly Patrick

Like most healthcare markets, the diagnostic cardiology market has had a bumpy ride in recent years. The COVID-19 ...

Home August 23, 2022
Home
Feature | Cardiac Diagnostics | By Adam Saltman, MD, PhD

Before opining on the future of cardiac health, I think it’s important to define what “cardiac health” actually is. If ...

Home May 04, 2022
Home
News | Cardiac Diagnostics

January 31, 2022 — Scientists have developed an artificial intelligence (AI) system that can analyze eye scans taken ...

Home January 31, 2022
Home
News | Cardiac Diagnostics

November 10, 2021 — Abbott released new global market research from its Beyond Intervention initiative, the company’s ...

Home November 10, 2021
Home
Feature | Cardiac Diagnostics | By Dave Fornell, DAIC Editor

October 29, 2021 — A new guideline for the evaluation and diagnosis of chest pain was released this week that provides ...

Home October 29, 2021
Home
Subscribe Now